Multi-centre susceptibility testing identifies broflanilide concentration for malaria vector control in sub-Saharan Africa, suggesting effective monitoring.
In this study, the preliminary discriminating concentration of broflanilide for An. gambiae mosquitoes was determined. The results of this study will provide a useful benchmark for susceptibility monitoring of wild mosquito populations in regions of sub-Saharan Africa into which VECTRON™ T500 is being introduced for malaria vector control.
No takes yet. Share an insight, caveat, or question.
Ando et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: